IBM and Roche Collaborate to Develop an AI-Driven Glucose Prediction System to Enhance Daily Life for People with Diabetes

IBM and Roche have collaborated to develop the Accu-Chek® SmartGuide Predict app, an AI-enabled tool designed to assist individuals with diabetes in managing their glycemic control. Launched recently in Switzerland, the app integrates predictive algorithms with Roche’s continuous glucose monitoring (CGM) sensor to help users anticipate potential hypoglycemic and hyperglycemic events, enhancing their daily diabetes management. Key features include real-time glucose forecasting and alerts for low glucose levels. Additionally, IBM’s watsonx platform will streamline the analysis of clinical study data, improving efficiency and insight generation. This innovative project will be showcased at the Swiss Economic Forum on June 5-6, highlighting the significance of cross-industry partnerships in advancing healthcare solutions. The collaboration exemplifies how AI technology can empower patients and improve therapeutic outcomes, demonstrating the potential of synergy between healthcare and technological expertise.

Source link